Testimony before the FDA's Tobacco Product Scientific Advisory Committee Regarding Modified Risk Tobacco Product Orders for ZYN

On January 22, 2026, Lindsey Stroud, President and Founder of Tobacco Harm Reduction 101, presented before the U.S. Food and Drug Administration's Tobacco Product Scientific Advisory Committee regarding modified risk tobacco product orders for ZYN oral nicotine pouches.

Read the full testimony below.

01-22-2026 THR101 Testimony RE MRTP Zyn.pdf

Download PDF • 122KB